BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Buscara L, Gross DA, Daniele N. Of rAAV and Men: From Genetic Neuromuscular Disorder Efficacy and Toxicity Preclinical Studies to Clinical Trials and Back. J Pers Med 2020;10:E258. [PMID: 33260623 DOI: 10.3390/jpm10040258] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Martínez-garcía J, Molina A, González-aseguinolaza G, Weber ND, Smerdou C. Gene Therapy for Acquired and Genetic Cholestasis. Biomedicines 2022;10:1238. [DOI: 10.3390/biomedicines10061238] [Reference Citation Analysis]
2 Bourg N, Vu Hong A, Lostal W, Jaber A, Guerchet N, Tanniou G, Bordier F, Bertil-Froidevaux E, Georger C, Daniele N, Richard I, Israeli D. Co-Administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy. Int J Mol Sci 2022;23:2016. [PMID: 35216132 DOI: 10.3390/ijms23042016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Matsuzaka Y, Hirai Y, Hashido K, Okada T. Therapeutic Application of Extracellular Vesicles-Capsulated Adeno-Associated Virus Vector via nSMase2/Smpd3, Satellite, and Immune Cells in Duchenne Muscular Dystrophy. Int J Mol Sci 2022;23:1551. [PMID: 35163475 DOI: 10.3390/ijms23031551] [Reference Citation Analysis]
4 Benatti HR, Gray-Edwards HL. Adeno-Associated Virus Delivery Limitations for Neurological Indications. Hum Gene Ther 2022;33:1-7. [PMID: 35049369 DOI: 10.1089/hum.2022.29196.hrb] [Reference Citation Analysis]
5 Duddy WJ, Duguez S. Understanding Neuromuscular Health and Disease: Advances in Genetics, Omics, and Molecular Function. J Pers Med 2021;11:438. [PMID: 34065209 DOI: 10.3390/jpm11050438] [Reference Citation Analysis]
6 Maestro S, Weber ND, Zabaleta N, Aldabe R, Gonzalez-Aseguinolaza G. Novel vectors and approaches for gene therapy in liver diseases. JHEP Rep 2021;3:100300. [PMID: 34159305 DOI: 10.1016/j.jhepr.2021.100300] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]